AusPAR: Idelalisib

Australian Public Assessment Report

AusPAR

AusPAR: Idelalisib [PDF, 1.28 MB]

AusPAR: Idelalisib [Word, 3.17 MB]

Attachment: Product Information: Idelalisib [PDF, 381.24 KB]

Attachment: Product Information: Idelalisib [Word, 518.5 KB]

Attachment: Extract from Clinical Evaluation Report Idelalisib [PDF, 2.98 MB]

Attachment: Extract from Clinical Evaluation Report Idelalisib [Word, 10.86 MB]

Device/Product Name

Zydelig

Active ingredients

Idelalisib

AusPAR Date

19 October 2017

Published

7 November 2017

Submission Number

PM-2015-02423-1-4

Submission Type

Extension of indications

Decision

Approved